|
|
||||||||
,2

* Laboratory of Cell Biology,
Laboratory of Molecular Biology, National Cancer Institute,
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
3Correspondence: Laboratory of Cell Biology, Building 37, Room 1A09, National Cancer Institute, National Institutes of Health, 37 Convent Drive MSC 4255, Bethesda, MD 20892-4255, USA. E-mail: mgottesman{at}nih.gov
The MDR1 multidrug transporter P-gp (P-glycoprotein) is an efflux pump that extrudes diverse hydrophobic drugs and peptides from cells. Since the entry of HIV-1 into cells involves an initial interaction of the viral gp41 hydrophobic peptide with the plasma membrane, a potential effect of P-gp on HIV-1 infectivity was explored. Virus production was greatly decreased when P-gp was overexpressed at the surface of a continuous CD4+ human T-leukemic cell line (12D7) infected with HIV-1NL43, a T-tropic molecular clone of HIV-1. P-gp overexpression did not significantly alter the surface expression or distribution of either the HIV-1 receptor CD4 or the coreceptor CXCR4. Reduction of HIV-1 infectivity in P-gp-expressing cells occurred both during the fusion of viral and plasma membranes and at subsequent step(s) in the HIV-1 life cycle.Lee, C. G. L., Ramachandra, M., Jeang, K.-T., Martin, M. A., Pastan, I., Gottesman, M. M. Effect of ABC transporters on HIV-1 infection: inhibition of virus production by the MDR1 transporter.
Key Words: ABC transporters acquired immunodeficiency syndrome AIDS P-glycoprotein virus entry
This article has been cited by other articles:
![]() |
Z. Wang, J. Wang, E. Tantoso, B. Wang, A. Y.P. Tai, L. L.P.J. Ooi, S. S. Chong, and C. G.L. Lee Signatures of recent positive selection at the ATP-binding cassette drug transporter superfamily gene loci Hum. Mol. Genet., June 1, 2007; 16(11): 1367 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Chang, C. J. Kochansky, and M. Shou The Role of P-glycoprotein in the Bioactivation of Raloxifene Drug Metab. Dispos., December 1, 2006; 34(12): 2073 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wang, S. Ngoi, J. Wang, S. S. Chong, and C. G. L. Lee The Promoter Region of the MDR1 Gene Is Largely Invariant, but Different Single Nucleotide Polymorphism Haplotypes Affect MDR1 Promoter Activity Differently in Different Cell Lines Mol. Pharmacol., July 1, 2006; 70(1): 267 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, B. Wang, K. Tang, E. J.D. Lee, S. S. Chong, and C. G.L. Lee A functional polymorphism within the MRP1 gene locus identified through its genomic signature of positive selection Hum. Mol. Genet., July 15, 2005; 14(14): 2075 - 2087. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Owen, B. Chandler, P. G. Bray, S. A. Ward, C. A. Hart, D. J. Back, and S. H. Khoo Functional Correlation of P-Glycoprotein Expression and Genotype with Expression of the Human Immunodeficiency Virus Type 1 Coreceptor CXCR4 J. Virol., November 1, 2004; 78(21): 12022 - 12029. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tang, L. P. Wong, E. J.D. Lee, S. S. Chong, and C. G.L. Lee Genomic evidence for recent positive selection at the human MDR1 gene locus Hum. Mol. Genet., April 15, 2004; 13(8): 783 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U. C. Sankatsing, J. H. Beijnen, A. H. Schinkel, J. M. A. Lange, and J. M. Prins P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1073 - 1081. [Full Text] [PDF] |
||||
![]() |
M. Siegsmund, U. Brinkmann, E. Schaffeler, G. Weirich, M. Schwab, M. Eichelbaum, P. Fritz, O. Burk, J. Decker, P. Alken, et al. Association of the P-Glycoprotein Transporter MDR1C3435T Polymorphism with the Susceptibility to Renal Epithelial Tumors J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1847 - 1854. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |